

%201.webp)


%201.webp)




LSPedia Global Serialization Series
序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
欢迎来到 LSPedia,在这里,创新与奉献相遇。
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。



%201.webp)


%201.webp)




序列化并非一刀切。美国、欧盟、亚洲和中东的法规要求各不相同,企业必须应对错综复杂的要求。您准备好实现全球合规了吗?
.avif)
如果您热衷于有所作为,并能在协作环境中茁壮成长,LSPedia 就是您的理想之选。


For decades, pharmacies have relied on a simple industry tradition: Loan & Borrow.
One pharmacy runs out of medication needed for a patient, so a nearby pharmacy loans them a bottle or a quantity of the drug. When the receiving pharmacy restocks, they pay it back. No paperwork. No tracking. Just professional courtesy.
But under today’s Drug Supply Chain Security Act (DSCSA), this long-standing practice is no longer a simple verbal agreement. In fact, Loan & Borrow often triggers regulatory obligations that many pharmacies don’t realize — and may put them at significant risk of noncompliance.
Here’s what pharmacies need to know.
Loan & Borrow is the informal transfer of medication between pharmacies, typically to address unexpected stock-outs. Pharmacy A “loans” a medication to Pharmacy B, and Pharmacy B “returns” the same drug or quantity later.
This practice was harmless in a pre-DSCSA world.
Today, however, any movement of serialized product that changes ownership matters, and so does the electronic data that must accompany it.
Yes. DSCSA defines a transaction as a transfer of product between persons in which a change of ownership occurs (1), so when a pharmacy loans a drug and later receives it back, the loan and the return are each a separate transaction with their own documentation. (1)
Many pharmacies are surprised to learn that Loan & Borrow is not exempt from DSCSA requirements. Even if the intention is to return the product later, DSCSA views each movement as a standalone transaction.
Here’s why:
1. Loaning the drug is one transaction.
Ownership transfers from Pharmacy A to Pharmacy B.
2. Returning the borrowed drug is a second transaction.
Ownership transfers back from Pharmacy B to Pharmacy A.
Under DSCSA, both transfers require:
That means Loan & Borrow isn’t an informal favor: it is regulated wholesale distribution.
Loan & Borrow creates several challenges under DSCSA:
Yes, but this exemption is very narrow. (1)
A pharmacy may transfer product to another pharmacy, but only for the purpose of filling an existing prescription for a specific, identified patient, and only the exact amount needed to fill that prescription (1).
This exemption does not apply to traditional Loan & Borrow exchanges and does not allow transferring stock for replenishment or future use.
For almost all real-world Loan & Borrow situations, DSCSA rules apply.
Under enhanced DSCSA requirements, every outbound transaction requires EPCIS data. If a pharmacy engages in:
…that pharmacy must be able to generate outbound EPCIS files with fully serialized transaction data.
Without outbound EPCIS capability, Loan & Borrow is not compliant, even if it's only occasional or “just helping another pharmacy out.”
LSPedia provides pharmacies with:
Whether you perform transfers once a year or every week, LSPedia ensures every transaction is DSCSA-compliant, auditable, and secure.
Loan & Borrow isn’t going away but it must evolve to meet today’s regulatory environment.
Is pharmacy Loan & Borrow allowed under DSCSA?
Yes, but only as a documented transaction. DSCSA defines a transaction as a transfer of product between persons in which a change of ownership occurs, so the loan and the return each count. Each one needs Transaction Information (TI) and a Transaction Statement (TS), both pharmacies must be authorized trading partners, and the records must be kept for at least 6 years.
Does returning a borrowed drug count as a second transaction?
Yes. When the borrowing pharmacy pays the loan back with product, ownership changes again, from the borrowing pharmacy back to the lending pharmacy. That return is a second, separate DSCSA transaction, so it needs its own Transaction Information and Transaction Statement, even when it is the same drug, strength and quantity that was originally loaned.
What counts as a “specific patient need” under DSCSA?
Under section 581(19) of the FD&C Act, a specific patient need is the transfer of a product from one pharmacy to another to fill a prescription for an identified patient. It does not include transfers to increase or replenish stock in anticipation of a potential need. Only the quantity needed for that prescription qualifies, so most Loan & Borrow exchanges do not.
Are small pharmacies exempt from DSCSA for Loan & Borrow?
Not from the transaction itself. FDA has exempted small dispensers, meaning pharmacies whose owning company has 25 or fewer full-time pharmacists and pharmacy technicians, from certain enhanced electronic, package-level tracing requirements until November 27, 2027 (2). Each loan and return is still a DSCSA transaction, and obligations such as trading only with authorized trading partners remain in effect.
How does OneScan Pharmacy Pro help with Loan & Borrow?
OneScan Pharmacy Pro generates outbound EPCIS data for pharmacy-to-pharmacy transfers, stores Transaction Information and Transaction Statements automatically, and applies compliance workflows that stop noncompliant transfers before they ship. That gives pharmacies an auditable record of every loan and every return when a state board of pharmacy, FDA or a trading partner asks for documentation.
If your pharmacy engages in any Loan & Borrow or inter-pharmacy transfers, now is the time to ensure you have the systems and processes needed to comply with DSCSA.
Talk to LSPedia’s team today to confirm your pharmacy is compliant and equipped with outbound EPCIS capabilities.
👉 Contact LSPedia Sales: sales@lspedia.com
👉 Request a demo: Contact the LSPedia team
Your compliance and your patients’ safety depend on it!